Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹10.84
Market cap: ₹243.1 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-292.9 Cr
P/E (TTM): -1.0×Sector 50.4×
Promoter holding: 51.84%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Management Change 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 Sep 2026 16:11 IST BSE

Management Change

Nectar Lifesciences Management Change

Nectar Lifesciences Limited has announced the appointment of Dr. Gunmala Suri as a Director. Additionally, three other directors have been re-appointed to the Board.

Read the filing ↗